Medical use of interferon-lambda for the treatment of fibrosis

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11975046
APP PUB NO 20240000893A1
SERIAL NO

18343944

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods for the treatment of fibrosis. The invention discloses new research which demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo and may be used to provide effective new therapies for the treatment of multiple types of fibrosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • UCB BIOPHARMA SRL; FIVE PRIME THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Johnson, Timothy Scott Berkshire, GB 6 6
Kellar, Danielle E San Francisco, US 1 0
Powers, Janine Wilmington, US 12 53
Twomey, Breda Berkshire, GB 5 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 7, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 7, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 7, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00